Terumo India has introduced Ultimaster Nagomi, a state-of-the-art Drug-Eluting Stent (DES) designed to revolutionize the treatment of Coronary Artery Disease (CAD).

This development marks a significant stride in the continual evolution of stent technologies, aiming to enhance the safety and efficacy of coronary artery treatments.

Drug-Eluting Stents (DES) are specialized devices crucial in addressing coronary artery disease, and ongoing investments in newer generations of stents underscore the commitment to advancing cardiovascular care.

Ultimaster Nagomi, the latest offering from Terumo India, stands out as a new generation DES capable of navigating complex arteries seamlessly while effortlessly adapting to vessels of varying sizes. Its optimal design ensures suitability for both small and large coronary arteries, providing a personalized stent selection for a broader spectrum of patients.

Shishir Agarwal, President and Managing Director of Terumo India, highlighted the significance of Ultimaster Nagomi, stating, "Ultimaster Nagomi embodies the legacy of Japanese technology, supported by robust clinical evidence from the Ultimaster family across various procedures. Our goal is to introduce cutting-edge Japanese technologies to benefit all Indian patients, allowing them access to the latest innovations in healthcare."

Nitin Stephen Abel, Director of Terumo Intervention Systems India, emphasized the evolving landscape of coronary treatments, stating, "Over the years, DES has evolved to become a preferred option for heart-related treatments. Given the rising occurrences of cardiovascular diseases, continuous advancements in treatment methods are essential. The introduction of Ultimaster Nagomi will be a notable development for the cardiac care ecosystem in India."

The launch of Ultimaster Nagomi signifies a significant contribution to advancing cardiac care in India, showcasing the commitment of Terumo India to bring cutting-edge technologies that address the evolving needs of patients dealing with Coronary Artery Disease.